Patents Assigned to USV Pharmaceutical Corporation
  • Patent number: 4405633
    Abstract: Provided is a method of treating asthma. The method is the administering to a patient requiring treatment of an effective dose of a benzoxazole-2-carboxylic acid or an ester or therapeutically-acceptable salt of benzoxazole-2-carboxylic acid.
    Type: Grant
    Filed: March 1, 1982
    Date of Patent: September 20, 1983
    Assignee: USV Pharmaceutical Corporation
    Inventors: Richard E. Brown, Bernard Loev, Vassil St. Georgiev
  • Patent number: 4400382
    Abstract: New triazoloquinoxalin-1,4-diones are described as well as the use thereof as anti-allergenic agents.
    Type: Grant
    Filed: March 16, 1981
    Date of Patent: August 23, 1983
    Assignee: USV Pharmaceutical Corporation
    Inventors: Richard E. Brown, Vassil St. Georgiev, Philip Kropp, Bernard Loev
  • Patent number: 4368201
    Abstract: Compounds having the structure: ##STR1## are novel and useful as antiallergic agents. The compounds are formulated with a pharmaceutical carrier for oral, parental, inhalational, or rectal means of administration.
    Type: Grant
    Filed: July 20, 1981
    Date of Patent: January 11, 1983
    Assignee: USV Pharmaceutical Corporation
    Inventor: Fu-chih Huang
  • Patent number: 4364940
    Abstract: A composition for the treatment of acne in the form of a solution, lotion or cream containing from about 1 to 10% by weight of a compound of the formula ##STR1## wherein R is an alkyl having up to 6 carbon atoms or aryl having up to 10 carbon atoms and R.sub.1 and R.sub.2 are independently hydrogen, lower alkyl having up to 6 carbon atoms, phenyl, phenyl-lower alkyl, lower alkylphenyl, halogen, halophenyl, trifluoromethyl, trifluoromethylphenyl, lower alkoxy, methylenedioxy, and lower alkoxyphenyl.
    Type: Grant
    Filed: February 23, 1981
    Date of Patent: December 21, 1982
    Assignee: USV Pharmaceutical Corporation
    Inventors: Edward S. Neiss, Bernard Loev
  • Patent number: 4355164
    Abstract: Provided are pyridothienopyridazine compounds of the formula ##STR1## wherein R.sub.1 is alkyl, alkenyl, alkynyl, halogen, nitro, cyano, carboxy, carboxyalkyl, carbalkoxy, alkanoyl, trihalomethyl, aryl, aralkyl, hetero, thio, thioalkyl, alkylmercapto, hydroxy, hydroxyalkyl, alkoxy, amino, aminoalkyl, alkylamino, sulfinyl, sulfonyl or methylenedioxy,n is an integer from 0 to 3 inclusive, andR.sub.2 and R.sub.3 are independently hydrogen, alkyl, alkenyl, alkinyl, hydroxy, hydroxyalkyl, alkoxy, halogen, amino, aminoalkyl, alkylamino, alkanoylamino, thio, thioalkyl, alkylmercapto, carboxy, carbalkoxy, alkylsulfinyl, alkylsulfonyl, arylsulfinyl, or arylsulfonyl, wherein the alkyl groups contain from 1 to 6 carbon atoms, the alkenyl and alkynyl groups contain from 2 to 6 carbon atoms, and the aryl groups contain from 6 to 10 carbon atoms. These compounds have anti-allergy activity.
    Type: Grant
    Filed: May 18, 1981
    Date of Patent: October 19, 1982
    Assignee: USV Pharmaceutical Corporation
    Inventor: Raymond D. Youssefyeh
  • Patent number: 4354027
    Abstract: New substituted triazoloquinoxalin-4-ones are described as well as the use thereof as anti-hypertensive agents.
    Type: Grant
    Filed: May 19, 1980
    Date of Patent: October 12, 1982
    Assignee: USV Pharmaceutical Corporation
    Inventors: Bernard Loev, John T. Suh, Bruce E. Williams, Vassil St. Georgiev
  • Patent number: 4347246
    Abstract: A compound of the formula ##STR1## wherein: R.sub.1 is independently lower alkyl having from 1 to 6 carbon atoms, lower alkenyl having from 2 to 6 carbon atoms, lower alkynyl having from 2 to 6 carbon atoms, hydroxy, hydroxyalkyl, alkoxy, thio, thioalkyl, alkylmercapto, amino, aminoalkyl, alkylamino, nitro, cyano, alkanoyl, carboxy, carboxyalkyl, carbalkoxy, carbalkoxyalkyl, halogen, alkylsulfoxy, alkylsulfonyl, sulfonyl, sulfonamido, trifluoromethyl, or methylenedioxy, wherein the alkyl group in hydroxyalkyl, thioalkyl, aminoalkyl, carboxyalkyl, alkoxy, alkylmercapto, alkylsulfoxy, alkanoyl, carbalkoxy, and carbalkoxyalkyl has from 1 to 6 carbon atoms,n is an integer from 1 to 4 inclusive,R.sub.2 is selected from the group consisting of hydrogen and cycloalkyl, wherein the cycloalkyl group contains from 3 to 16 carbon atoms,R.sub.3 and R.sub.4 are hydrogen, andY is oxygen, sulphur, .dbd.NR.sub.1, .dbd.NOR.sub.1 or .dbd.N--NH.sub.2, R.sub.1 being the same as defined above.
    Type: Grant
    Filed: May 15, 1980
    Date of Patent: August 31, 1982
    Assignee: USV Pharmaceutical Corporation
    Inventors: John T. Suh, Bruce E. Williams, Jerry W. Skiles, Bernard Loev
  • Patent number: 4342692
    Abstract: Compounds of the formulae: ##STR1## wherein, Z and Y are each alkylene containing one to about five carbon atoms in the principal chain or said alkylene substituted with OH, alkanoyloxy, alkoxy, mercapto or alkylmercapto;each of R.sub.1, R.sub.2 and R.sub.3 is independently H, alkyl, aryl, halo, alkoxy, alkenyloxy, alkylsulfinyl, alkylsulfonyl, alkylmercapto, cyano, carboxy, carbalkoxy, carboxamido, sulfamoyl, trifluoromethyl, hydroxy, hydroxyalkyl, acyloxy, alkylamino, sulfonylamino, or acylamino; and R.sub.1 and R.sub.2, when taken together, form a methylenedioxy or --O--CO--O--;Ar is heteroaryl, cycloalkyl or ##STR2## wherein, R.sub.1, R.sub.2 and R.sub.3 are as hereindescribed; andR is H, alkyl, cycloalkyl, aryl, aralkyl, alkenyl, alkynyl, carboalkoxy, or CONR.sub.4 R.sub.5 wherein each of R.sub.4 and R.sub.5 is H or alkyl; wherein the total number of carbon atoms in each hydrocarbyl group is up to 10;and ##STR3## wherein, each of R.sub.1 and R.sub.
    Type: Grant
    Filed: October 20, 1980
    Date of Patent: August 3, 1982
    Assignee: USV Pharmaceutical Corporation
    Inventors: John T. Suh, Rack H. Chung, Nai-Yi Wang, Jeffrey N. Barton
  • Patent number: 4331600
    Abstract: Compounds of the formula ##STR1## wherein, Y and Z are each H, alkyl, halo, alkoxy, trifluoromethyl, hydroxy, alkanoyloxy, or alkanoylamino;X is F, Cl Br or NR.sub.1 R.sub.2 in which R.sub.1 and R.sub.2 are each hydrogen, alkyl, alkenyl, alkynyl, aryl, aralkyl or cycloalkyl; andR is H, alkyl, cycloalkyl or aralkyl; and salts thereof.The compounds have utility as anti-hypertensive and diuretic agents and as intermediates for the preparation of other anti-hypertensive and diuretic agents.
    Type: Grant
    Filed: October 31, 1980
    Date of Patent: May 25, 1982
    Assignee: USV Pharmaceutical Corporation
    Inventors: Frederick A. Golec, Jr., Joseph Auerbach
  • Patent number: 4329345
    Abstract: Compounds of the formula ##STR1## wherein R is hydrogen, alkyl, alkoxy, halo, amino, alkylamino, dialkylamino, hydroxy, nitro, trifluoromethyl, mercapto, or alkylmercapto, and may be the same or different,n is an integer from 2 to 4, andR.sub.1 and R.sub.2 are hydrogen or alkyl and may be the same or different, or R.sub.1 and R.sub.2 taken together with the nitrogen to which they are attached may be pyrrolidino, piperidino or morpholinoand their pharmaceutically acceptable, non-toxic acid addition salts have anti-arrhythmic activity.
    Type: Grant
    Filed: April 28, 1980
    Date of Patent: May 11, 1982
    Assignee: USV Pharmaceutical Corporation
    Inventors: James R. Shroff, Rohit Desai
  • Patent number: 4307091
    Abstract: Therapeutic compositions containing as active principle, a benzoxazindione or pharmaceutically-acceptable acid addition salt thereof are useful in the treatment of allergy.
    Type: Grant
    Filed: May 12, 1980
    Date of Patent: December 22, 1981
    Assignee: USV Pharmaceutical Corporation
    Inventors: Richard E. Brown, Vasil St. Georgiev, Bernard Loev, Robert Mack
  • Patent number: 4304771
    Abstract: Compounds of the structure: ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, and R.sub.6 are hydrogen, alkyl, alkenyl, alkynyl, phenyl-alkyl, or cycloalkyl,n is an integer from 0 to 4 inclusive,M is heterocyclic or heterocyclic alkyl,Y is hydroxy, alkoxy, amino, or substituted amino, amino-alkanoyl, aryloxy, aminoalkoxy, or hydroxyalkoxy, andR.sub.7 is hydrogen, alkanoyl, carboxylalkanoyl, hydroxyalkanoyl, amino-alkanoyl, cyano, amidino, carbalkoxy, ZS, or ##STR2## wherein Z is hydrogen, alkyl, kydroxyalkyl, aminoalkyl or the radical ##STR3## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, n, M and Y are as described above; and where Y is hydroxy their nontoxic, pharmaceutically acceptable alkali metal, alkaline earth metal, and amine salts.
    Type: Grant
    Filed: October 24, 1980
    Date of Patent: December 8, 1981
    Assignee: USV Pharmaceutical Corporation
    Inventors: John T. Suh, Jerry W. Skiles, Bruce E. Williams, Alfred Schwab
  • Patent number: 4304914
    Abstract: Compounds of the formula ##STR1## wherein each of R, R.sub.1 and R.sub.2 is independently H, alkyl, alkenyl, alkoxy, halo, hydroxy, trifluoromethyl, amino, alkylamino, cyano and nitro;R.sub.3 is carbalkoxy, carboxamide alkanoyl, trifluoromethyl and cyano; andAr is heteroaryl or ##STR2## wherein R.sub.4 and R.sub.5 have the same meaning as each of R, R.sub.1 and R.sub.2 ; and acid addition salts thereof have cardiotonic and hypertensive activity.
    Type: Grant
    Filed: July 7, 1980
    Date of Patent: December 8, 1981
    Assignee: USV Pharmaceutical Corporation
    Inventors: James R. Shroff, Bernard Loev
  • Patent number: 4302591
    Abstract: Iminobenzyl dihydropyridines of the formula ##STR1## wherein, each R is alkyl, alkenyl, alkynyl, cycloalkyl, aryl, aralkyl, sulfonamido, halogen, alkoxy, alkenyloxy, alkynyloxy, cyano, hydroxy, acyloxy, nitro, amino, alkylmercapto, alkylamino, alkanoylamino, carbalkoxyamino, carboxy, methanesulfonyl, carbalkoxy or trifluoromethyl;each R.sub.4 is lower alkoxy;each R.sub.2 is lower alkyl;and R.sub.3 is alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclic or ##STR2## wherein R is as previously defined; have anti-hypertensive activity.
    Type: Grant
    Filed: September 2, 1980
    Date of Patent: November 24, 1981
    Assignee: USV Pharmaceutical Corporation
    Inventors: James R. Shroff, Bernard Loev
  • Patent number: 4302442
    Abstract: Migration of suspended materials in nail enamels is prevented by the addition thereto of from about 0.10 to 5.0% by weight of a phosphatide such as lecithin. Settling and migration of suspended materials in nail enamels is prevented by the addition thereto of from 0.10 to 5.0% by weight of a phosphatide such as lecithin and from about 0.04 to 0.20% by weight of a cosmetically acceptable acid.
    Type: Grant
    Filed: December 18, 1980
    Date of Patent: November 24, 1981
    Assignee: USV Pharmaceutical Corporation
    Inventors: Robert Socci, Anthony Gunderman, Eustace Fotiu, Bernard Kabacoff
  • Patent number: 4298742
    Abstract: New benzoxazole-2-carboxylic acid esters are described. These compounds are useful as anti-allergic reagents.
    Type: Grant
    Filed: May 12, 1980
    Date of Patent: November 3, 1981
    Assignee: USV Pharmaceutical Corporation
    Inventors: Richard E. Brown, Vasil St. Georgiev, Bernard Loev
  • Patent number: 4287203
    Abstract: Antihypertensive compounds of the structure ##STR1## wherein: n is an integer from 0 to 2 inclusive,R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, and R.sub.7 are independently hydrogen, alkyl having from 1 to 6 carbon atoms, alkenyl having from 2 to 6 carbon atoms, alkynyl having from 2 to 6 carbon atoms, cycloalkyl having from 3 to 16 carbon atoms, phenyl, benzyl, tolyl, naphthyl, phenethyl, indanyl, tetrahydronaphthyl, decanydronaphthyl, pyridyl, quinolyl, pyrrolidyl, pyrrolyl, morpholinyl, thiomorpholinyl, furyl, furfuryl, tetrahydrofurfuryl, benzimidazole, thienyl, imidolyl, or tetrahydroindolyl, and where the R.sub.1 to R.sub.7 groups are alkyl, said groups carrying a substituent selected from hydroxy, alkoxy, amino, carboxy, or carbalkoxy, the alkyl group in alkoxy and carbalkoxy having from 1 to 6 carbon atoms, or R.sub.2 taken together with R.sub.3 and the carbons to which they are attached is tetrahydronaphthyl or phenyl, and when phenyl R.sub.1 and R.sub.4 are absent, or R.sub.6 and R.sub.
    Type: Grant
    Filed: April 23, 1980
    Date of Patent: September 1, 1981
    Assignee: USV Pharmaceutical Corporation
    Inventors: John T. Suh, Bruce E. Williams, Jerry W. Skiles, Bernard Loev
  • Patent number: 4283541
    Abstract: Compounds of the formula ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are independently hydrogen, lower alkyl, phenyl or phenyl-lower alkyl,n is an integer from 1 to 5, andm is an integer from 2 to 5 have antiarrhythmic activity.
    Type: Grant
    Filed: May 27, 1980
    Date of Patent: August 11, 1981
    Assignee: USV Pharmaceutical Corporation
    Inventors: James R. Shroff, Rohit Desai
  • Patent number: 4276292
    Abstract: New triazolobenzoxazinones are described as well as the use thereof as anti-allergenic agents.
    Type: Grant
    Filed: May 12, 1980
    Date of Patent: June 30, 1981
    Assignee: USV Pharmaceutical Corporation
    Inventors: Vasil St. Georgiev, Bernard Loev, Robert Mack, John Musser
  • Patent number: 4269846
    Abstract: New benzoheterocyclic oxadiazolones and triazolones are described. These compounds are useful as anti-allergic reagents.
    Type: Grant
    Filed: October 29, 1979
    Date of Patent: May 26, 1981
    Assignee: USV Pharmaceutical Corporation
    Inventors: Fu C. Huang, John H. Musser